Tag Archives: Centers

gI_111192_AAPCC-logo-new-with-border-20121

American Association of Poison Control Centers Publishes Joint Position Statement on Expanding Access to Naloxone


Alexandria, VA (PRWEB) October 07, 2014

On Oct. 6, 2014, the American Association of Poison Control Centers (AAPCC), joined with the American Academy of Clinical Toxicology (AACT) and American College of Medical Toxicology (ACMT), to jointly publish a position statement advocating expanding the access to naloxone throughout the United States in the October 2014 issue of Clinical Toxicology.

Over the past three decades, drug overdose deaths in the United States have tripled and in 2008, unintentional poisoning deaths surpassed the number of motor vehicle deaths for the first time. Of the 38,329 drug overdose deaths in the United States in 2010, 60 percent (22,134) were related to pharmaceuticals, with 75 percent of those deaths involving prescription opioid analgesics. Concurrently, heroin deaths have risen 55 percent between 2000 and 2010.

In overdose scenarios, opioids (including morphine, oxycodone, hydrocodone, methadone and fentanyl) cause slowed breathing which can lead to hypoxia and, if untreated, death. Timely administration of naloxone reverses the opioid-induced slowing of the respiratory rate and can save a person’s life. Naloxone is very effective, inexpensive, and has been used for this purpose in hospitals and by emergency medical systems since 1970. Currently in the U.S., naloxone is principally administered in the health care setting, but use by laypersons is becoming more common.

“Deaths from prescription and non-prescription opioids have reached epidemic proportions,” said AACT President Robert S. Hoffman, MD. “Naloxone is easy to administer, very safe and can rapidly reverse toxicity. Unfortunately, help is often too far away. Putting naloxone into the hands of laypersons via a ‘Bystander Naloxone Training’ program can help save lives when time is of the utmost importance.”

Naloxone administered by laypersons is prescribed and distributed as part of “overdose education and naloxone distribution” programs. The word bystander refers to a family member, friend, or stranger who is in close proximity to the victim at the time of the overdose and specifically not a trained health care provider.

Naloxone educations programs include the following key elements:

1.    Identify opioids licit and illicit, and non-opioids

2.    Recognize a patient with an opioid overdose (vs. opioid use)

3.    Attempt to rouse and stimulate victim

4.    Call 911

5.    Rescue breathing

6.    Administer naloxone intramuscularly or intranasally

7.    Place the victim on their left side while awaiting for 911 to arrive

8.    Aftercare (definitive pre-hospital and hospital medical care for the overdose and its complications).

“Due to concerns of police involvement cited as a main reason for not calling 911, it is critical we have a system in place to rapidly respond to these increasing opioid overdoses,” said Dr. Hoffman. “Until immunity laws for drug-related emergencies are broader and better communicated, naloxone is a common sense means to prevent unnecessary and avoidable deaths.”

For more information, the media may contact Brett Schuster, AAPCC associate manager, Public Relations and Government Affairs, at 703.894.1865 or schuster(at)aapcc(dot)org.

AAPCC supports the nation’s 55 poison center members in their efforts to treat and prevent drug, consumer product, animal, environmental and food poisoning. Members staff the Poison Help hotline at 1-800-222-1222 that provides free, confidential, expert medical advice 24 hours a day, seven days a week, 365 days a year from toxicology specialists, including nurses, pharmacists, physicians, and poison information providers. In addition, AAPCC maintains the only poison information and surveillance database in the United States, providing real-time monitoring of unusual poisoning patterns, chemical exposures and other emerging public health hazards. AAPCC partners with federal agencies such as EPA, HRSA and the CDC, as well as private industry.

To learn more, visit http://www.aapcc.org, like us on Facebook, follow us on Twitter, or read our blog at aapcc.wordpress.com. To join your voice with other poison center supporters, register for AAPCC advocacy network at http://www.capwiz.com/aapcc – click on “Action E-List.”







Insight Behavioral Health Centers Welcomes Dr. Peter Zemenides

Chicago, IL (PRWEB) April 08, 2015

Chicago-based Insight Behavioral Health Centers (http://www.InsightBHC.com), a leading provider of comprehensive treatment for eating, obesity, mood and anxiety disorders, today announced that Peter Zemenides, MD has joined its medical team. Dr. Zemenides will oversee the delivery of care in the Mood and Anxiety Program and Compulsive Overeating Recovery Effort (CORE). In his role, Dr. Zemenides will collaborate with Insight leadership to shape the mood and anxiety program and CORE treatment philosophies, will provide guidance and mentorship to the multidisciplinary treatment team, and will provide direct patient care.

“With the addition of Dr. Zemenides, Insight Behavioral Health Centers possesses unmatched medical and clinical expertise in the treatment of mood, anxiety and binge eating disorders in the Chicagoland area,” explains Susan McClanahan, PhD, Founder and President of Insight. “Patients and families struggling with the complexities of these disorders benefit greatly from compassionate psychiatric support at all stages of the treatment continuum.”

Insight’s medically-supported mood and anxiety and CORE treatment programs offer comprehensive, evidence-based treatment for adults and adolescents. A multidisciplinary treatment team includes psychiatrists, physicians, psychologists, social workers, Master’s-level counselors, Registered Yoga Therapists, expressive therapists and marriage and family therapists. While the Residential level of care offers 24/7 support and observation, staff-supported housing is available for male and female adults at the Partial Hospitalization and Intensive Outpatient levels of care as well. Learn more about Insight’s programming for adults and adolescents here: http://www.InsightBHC.com.

Prior to joining Insight’s medical leadership team, Dr. Zemenides served as Acting Medical Director of the McClendon Center in Washington, DC, a leading treatment center serving the needs of adults diagnosed with serious and persistent mental illness. In this role, he oversaw the assessment and management of patients with psychiatric conditions, including initial and follow up assessment, medication management, psychotherapy, ordering/interpreting diagnostic tests and coordination of care within an interdisciplinary team framework. Dr. Zemenides is committed to training the next generation of physicians in the field of psychiatry, serving as a Clinical Case Conference Facilitator, Psychiatry Small Group Facilitator and Guest Lecturer at the George Washington University School of Medicine. He has also participated in research initiatives in the Neurology departments at both the University of Illinois Chicago College of Medicine and Northwestern University. Dr. Zemenides speaks widely on the topic of mental illness at symposia in the United States and abroad, and has authored numerous articles on topics including psychopharmacology, behavioral analysis, psychology of terrorism, delirium and circadian rhythms. He earned his MD and completed his Residency at the George Washington University School of Medicine following completion of his BA at Northwestern University.

For more information about mood, anxiety and eating disorder treatment at Insight Behavioral Health Centers, call (312) 487-2418 or visit http://www.InsightBHC.com to chat confidentially with a Clinical Assessment Specialist.

About Insight Behavioral Health Centers:

Insight Behavioral Health Centers specializes in treatment for female and male adolescents and adults dealing with eating, mood and anxiety disorders, as well as obesity. Residential, Partial Hospitalization, Intensive Outpatient and general Outpatient levels of care are offered at five Chicago-area locations, including Northbrook, Evanston, Oak Park and two treatment centers in downtown Chicago. Insight is accredited by the Joint Commission and is a teaching affiliate of Northwestern University Medical School and Rush University Medical School. Insight partners with Denver-based Eating Recovery Center, an international center providing comprehensive, specialized eating disorders treatment for female and male adults, adolescents and children. For more information, visit http://www.InsightBHC.com or call (312) 487-2418.







gI_111192_AAPCC-logo-new-with-border-2012

American Association of Poison Control Centers Publishes Joint Position Statement on Expanding Access to Naloxone


Alexandria, VA (PRWEB) October 07, 2014

On Oct. 6, 2014, the American Association of Poison Control Centers (AAPCC), joined with the American Academy of Clinical Toxicology (AACT) and American College of Medical Toxicology (ACMT), to jointly publish a position statement advocating expanding the access to naloxone throughout the United States in the October 2014 issue of Clinical Toxicology.

Over the past three decades, drug overdose deaths in the United States have tripled and in 2008, unintentional poisoning deaths surpassed the number of motor vehicle deaths for the first time. Of the 38,329 drug overdose deaths in the United States in 2010, 60 percent (22,134) were related to pharmaceuticals, with 75 percent of those deaths involving prescription opioid analgesics. Concurrently, heroin deaths have risen 55 percent between 2000 and 2010.

In overdose scenarios, opioids (including morphine, oxycodone, hydrocodone, methadone and fentanyl) cause slowed breathing which can lead to hypoxia and, if untreated, death. Timely administration of naloxone reverses the opioid-induced slowing of the respiratory rate and can save a person’s life. Naloxone is very effective, inexpensive, and has been used for this purpose in hospitals and by emergency medical systems since 1970. Currently in the U.S., naloxone is principally administered in the health care setting, but use by laypersons is becoming more common.

“Deaths from prescription and non-prescription opioids have reached epidemic proportions,” said AACT President Robert S. Hoffman, MD. “Naloxone is easy to administer, very safe and can rapidly reverse toxicity. Unfortunately, help is often too far away. Putting naloxone into the hands of laypersons via a ‘Bystander Naloxone Training’ program can help save lives when time is of the utmost importance.”

Naloxone administered by laypersons is prescribed and distributed as part of “overdose education and naloxone distribution” programs. The word bystander refers to a family member, friend, or stranger who is in close proximity to the victim at the time of the overdose and specifically not a trained health care provider.

Naloxone educations programs include the following key elements:

1.    Identify opioids licit and illicit, and non-opioids

2.    Recognize a patient with an opioid overdose (vs. opioid use)

3.    Attempt to rouse and stimulate victim

4.    Call 911

5.    Rescue breathing

6.    Administer naloxone intramuscularly or intranasally

7.    Place the victim on their left side while awaiting for 911 to arrive

8.    Aftercare (definitive pre-hospital and hospital medical care for the overdose and its complications).

“Due to concerns of police involvement cited as a main reason for not calling 911, it is critical we have a system in place to rapidly respond to these increasing opioid overdoses,” said Dr. Hoffman. “Until immunity laws for drug-related emergencies are broader and better communicated, naloxone is a common sense means to prevent unnecessary and avoidable deaths.”

For more information, the media may contact Brett Schuster, AAPCC associate manager, Public Relations and Government Affairs, at 703.894.1865 or schuster(at)aapcc(dot)org.

AAPCC supports the nation’s 55 poison center members in their efforts to treat and prevent drug, consumer product, animal, environmental and food poisoning. Members staff the Poison Help hotline at 1-800-222-1222 that provides free, confidential, expert medical advice 24 hours a day, seven days a week, 365 days a year from toxicology specialists, including nurses, pharmacists, physicians, and poison information providers. In addition, AAPCC maintains the only poison information and surveillance database in the United States, providing real-time monitoring of unusual poisoning patterns, chemical exposures and other emerging public health hazards. AAPCC partners with federal agencies such as EPA, HRSA and the CDC, as well as private industry.

To learn more, visit http://www.aapcc.org, like us on Facebook, follow us on Twitter, or read our blog at aapcc.wordpress.com. To join your voice with other poison center supporters, register for AAPCC advocacy network at http://www.capwiz.com/aapcc – click on “Action E-List.”







Harbor Village Detox Extends Treatment for Drug & Alcohol Abuse to Mass. in Response to Treatment Centers Denying Victims of Abuse Insurance Coverage

USA (PRWEB) March 18, 2015

Drug and alcohol addiction treatment is a costly enterprise for a nationwide epidemic, that often bars essential medical treatment from victims suffering of drug and alcohol substance abuse disorders. According to Wbur on March 11th, drug and alcohol rehabilitation centers in the state of Mass. are unable to get the drug and alcohol addiction treatment they need because insurance providers will not cover addiction treatment. Some people were allegedly released because of insufficient insurance coverage. Harbor Village Detox is an inpatient medical detox center committed to the long term recovery of its patients. The addiction treatment center is governed on the ideal that all people suffering from drug and alcohol addiction should have uncompromised access to medical treatment, that will save lives from fatal overdose.

Harbor Village Detox is extending their complete services to the state of Mass. to encourage victims of drug and alcohol addiction with the addiction treatment they need to save their lives from continued abuse. The facility offers insurance coverage for most major insurances, and offers 100% financing in some cases. Their inpatient medical detox facility is located in South Florida. Flight accommodations are available in certain circumstances, and their dedicated driver will pick up patients from the airport directly.

A medical associate of Harbor Village Detox comments, “It’s so important for drug addicts to get treatment as soon as they seek it, undaunted. It’s such a difficult process to get addicts to admit they have a problem and seek treatment in the first place. Turning them away from drug and alcohol rehabilitation often derails people from trying to get help at all. Our facility gives patients a warm environment to recover, and offers the protection of continued treatment despite their individual situations. We pride ourselves in not turning anyone who needs our help away.”

Harbor Village Detox helps patients uncover the inner crux of addiction, and provides patients with coping strategies to address feelings of anger, depression, and anxiety perpetuating drug and alcohol addiction. The facility offers drug detox and a variety of other drug and alcohol rehabilitation service to ensure continued treatment and the avoidance of relapse. Providing a 24/7 medically monitored facility, Harbor Village Detox provides patients the security they need to recover with ease.

For more information on the inpatient medical detox facility, Harbor VIllage Detox, visit http://harborvillageflorida.com/ or call Harbor Village Detox directly 1-855-290-4261.